Haemostasis with Xylometazoline Hydrochloride 1% (Trade Name Otriven) during Invasive Endoscopy an Alternative to the Usual Procedures

Gerd Helmecke
Additional contact information
Gerd Helmecke: Facharzt für Innere Medizin, Germany

Biomedical Journal of Scientific & Technical Research, 2024, vol. 56, issue 1, 47737-47738

Abstract: The implementation of Xylometazoline hydrochloride 1% (marketed under the trade name Otriven) as a haemostatic agent during invasive endoscopy procedures offers a viable alternative to traditional haemostasis methods. This retrospective study, grounded in four decades of clinical practice, evaluates the efficacy and safety of Xylometazoline hydrochloride 1% in over 32,000 endoscopic procedures, including colonoscopies, gastroscopies, and bronchoscopies.

Keywords: Journals on Medical Drug and Therapeutics; Journals on Emergency Medicine; Physical Medicine and Rehabilitation; Journals on Infectious Diseases Addiction Science and Clinical Pathology; Open Access Clinical and Medical Journal; Journals on Biomedical Science; List of Open Access Medical Journal; Journals on Biomedical Engineering; Open Access Medical Journal; Biomedical Science Articles; Journal of Scientific and Technical Research (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.008801.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.008801.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:56:y:2024:i:1:p:47737-47738

DOI: 10.26717/BJSTR.2024.56.008801

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().